Lentigo Maligna Melanoma: Symptoms, Diagnosis and Treatment

Lentigo Maligna Melanoma (LMM) is a slow-growing but potentially deadly form of melanoma that primarily affects older adults with significant sun exposure. It accounts for about 5-15% of all melanomas and is most commonly found on the face, neck, and other sun-exposed areas 

Though it progresses slowly, early detection and treatment are essential to prevent its transformation into invasive melanoma. This article provides an in-depth look at LMM, covering its characteristics, diagnosis, treatment options, prognosis, and prevention strategies. 

[signup]

What is Lentigo Maligna Melanoma?

Lentigo Maligna Melanoma (LMM) is one of the four major types of melanoma, but it is unique due to its slow growth and strong association with chronic sun exposure. Understanding what makes LMM different is essential for early detection and appropriate treatment.

Definition and Overview

LMM begins as Lentigo Maligna (LM), a precancerous lesion that remains in the top layer of the skin (epidermis) for years before potentially becoming invasive. Unlike nodular or superficial spreading melanoma, LMM develops gradually and is often detected in its early stages.

How LMM Differs from Other Melanomas

LMM is distinct from other melanoma types due to its slow growth and strong link to sun exposure (Table 1).

Table 1: Comparison of the four major forms of melanoma.

Epidemiology and Global Prevalence

LMM is more common in fair-skinned individuals and in areas with high UV exposure. However, it is becoming more widely diagnosed due to increased awareness and better screening.

Geographic characteristics

• Australia & New Zealand: Highest global rates.  Risk factors include a high UV index and an outdoor lifestyle.
• United States & Europe: Moderate prevalence.  This is attributed to an aging population and sun exposure. 
• Asia & Africa: Lower incidence.  More melanin in the skin provides protection.  

Signs and Symptoms

During the early stages of LMM, it can be mistaken for harmless skin lesions like age spots or freckles. Recognizing the warning signs can lead to earlier intervention and better outcomes.

Physical Appearance and Characteristics

LMM usually appears as a flat, brownish patch with irregular borders that slowly enlarges over time. Typical LMM characteristics:

• Color: Brown, tan, black, or gray shades.
• Border: Irregular, blurry, or jagged edges
• Size: Starts small but expands over the years.

Early Symptoms and Red Flags

Since LMM can look like harmless skin changes, monitoring new or evolving skin lesions is important, especially in sun-exposed areas.

• Darkening, spreading, or irregular color variations.
• A lesion that continues growing over time.
• New pigmentation in areas previously clear of moles. A dermatologist should evaluate any persistent, enlarging lesions.

Diagnostic Procedures and Techniques

Since LMM often resembles benign age spots or other skin lesions, a thorough examination and advanced diagnostic tools are often needed to confirm the diagnosis.

Clinical Examination and Patient History

The first step in diagnosing LMM involves a detailed patient history and a thorough dermatological exam. Understanding a patient's risk factors, such as long-term sun exposure, history of skin cancer, and family history of melanoma, helps guide the diagnostic process.

Following the patient's history, a healthcare provider performs a comprehensive skin examination to assess irregularly pigmented lesions that may indicate LMM.

If a suspicious lesion is identified, dermoscopy is typically the next step. This non-invasive imaging technique magnifies the skin, allowing dermatologists to examine fine details and patterns that are not visible to the naked eye, improving the accuracy of the diagnosis.

Advanced Diagnostic Tools

A biopsy and imaging tests are essential for confirming LMM and assessing whether it has spread.

Imaging Tests

Advanced imaging techniques help evaluate lymph node involvement and detect potential metastases.

Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET) scans are used to assess enlarged lymph nodes and determine if the cancer has spread beyond the skin.

Biopsy Methods

If LMM is suspected, a biopsy is necessary to confirm the diagnosis and guide treatment. Biopsy methods include:  

• Dermoscopy: Magnifies skin lesions for better analysis.
• Confocal Microscopy: Non-invasive imaging that detects cellular changes.
• Excisional Biopsy: Removes the lesions for laboratory testing.

Treatment Options for Lentigo Maligna Melanoma

Treatment for LMM depends on tumor size, location, TNM stage, and the patient’s overall health. The goal is to remove the melanoma completely while preserving as much healthy skin as possible.

Staging for LMM is similar to staging for all melanomas (Table 2).  

Table 2:  Melanoma staging.

Surgical Treatments

Surgery is the preferred method of treatment, particularly for early-stage lesions. Common surgical techniques used:

• Wide Local Excision: Best for small, well-defined LMM.
• Mohs Surgery: Best for facial lesions requiring precision.  

Non-Surgical Treatments

Surgical removal remains the most effective treatment, but non-surgical options are available when necessary. Alternative therapies may be considered for patients unable to undergo surgery.

• Radiation Therapy: May be used when surgery is not an option.
• Cryotherapy: Freezes abnormal cells but is less commonly used.
• Topical Treatments: Topical imiquimod (immune-modulating cream) in select cases.

Prognosis and Management

LMM has a high survival rate, with reported 5-year survival rates as high as 100% when treated early.  However, advanced-stage, invasive LMM tumors have lower survival rates similar to those of other melanomas.  

Several key factors influence prognosis, including:

• Tumor Thickness: The thicker the tumor, the higher the likelihood of it spreading beyond the skin.
• Ulceration: LMM lesions that develop ulceration (skin breakdown) are associated with poorer survival outcomes.
• Age & Overall Health: Younger patients with no or minor underlying health conditions tend to recover more successfully and have better long-term outcomes.

Long-Term Management and Follow-Up

Even after successful treatment, ongoing monitoring is essential to prevent recurrence and detect new skin cancers early.

• Regular Dermatologist Visits: Patients should have full-body skin exams every 6 to 12 months.
• Self-Skin Checks: Monthly self-examinations can help detect new or changing moles before they become problematic.
• UV Protection: Avoiding excessive sun exposure and using daily sunscreen reduces the risk of developing new melanomas.

By maintaining consistent follow-up care, patients can lower their risk of recurrence and improve long-term outcomes.

Prevention and Risk Reduction

Prevention is key to reducing the risk of developing LMM and improving long-term outcomes. Individuals can proactively protect their skin and overall health by understanding modifiable risk factors.

Sun Protection Strategies

Since chronic UV exposure is the primary cause of LMM, sun safety measures can significantly reduce risk.

Use Broad-Spectrum Sunscreen

• The FDA recommends using a broad-spectrum sunscreen with SPF 30 or higher to reduce UV exposure risk.
• Reapply every two hours and immediately after swimming or sweating.
• Choose broad-spectrum formulas that protect against UVA and UVB rays.

Wear Protective Clothing and Accessories

• Wide-brimmed hats, long sleeves, and sunglasses reduce UV exposure.
• Ultraviolet Protection Factor (UPF-rated) clothing provides additional protection.

Avoid Tanning Beds and Excessive Sun Exposure

• Tanning beds emit concentrated UV radiation, increasing melanoma risk. The WHO and FDA classify tanning beds as carcinogenic, with evidence linking them to an increased risk of melanoma.
• Limit direct sun exposure between 10 AM and 4 PM, when UV rays are strongest.

Monitor UV Index and Seek Shade

• Use weather apps to check the daily UV index.
• When UV levels are high, stay in shaded areas and avoid prolonged sun exposure.

Global Perspectives and Research Developments

LMM is a worldwide concern, but treatment approaches and diagnostic advancements vary by region. Understanding these differences helps in shaping more effective prevention and care strategies.

Comparative Analysis of Treatment Approaches Worldwide

LMM diagnosis and treatment vary worldwide due to differences in healthcare access, dermatology resources, and cultural attitudes toward sun protection. Regions with strong sun safety initiatives and advanced medical care see better prevention and early detection of LMM.

• United States & Europe: Mohs surgery and immunotherapy are the primary treatment options.
• Australia & New Zealand: Focus on aggressive sun protection campaigns to reduce incidence.
• Asia & Africa: Lower LMM rates, but cases are rising due to lifestyle changes. Limited screening programs and dermatologist access pose challenges to early diagnosis and treatment.

Latest Research Findings

Cutting-edge research in AI, immunotherapy, and targeted therapies may revolutionize the early detection and treatment of LMM.  Examples of new findings and ongoing areas of research:

• Artificial intelligence (AI) tools are being developed to detect melanoma more accurately in the early stages using imaging technology.
• Gene Editing & CRISPR-Based Treatments: Scientists are exploring gene therapy to correct genetic mutations responsible for melanoma.
• Scientists are exploring genetic mutations in LMM tumors to develop new drug therapies that block tumor growth.‍
• BRAF & MEK inhibitors (used in other melanoma types) are being investigated for potential use in late-stage LMM cases.

[signup]

Key Takeaways

• Lentigo Maligna Melanoma (LMM) is a slow-growing but potentially serious type of melanoma that primarily affects older adults with significant sun exposure. It commonly appears on the face, scalp, and neck.
• Early detection is critical for successful treatment, as LMM can remain in a non-invasive stage (Lentigo Maligna) for years before becoming aggressive.
• Key warning signs include a gradually enlarging brown, tan, or black patch with irregular borders, which may resemble an age spot but continue to grow over time.
• Diagnosis requires specialized tools such as dermoscopy, confocal microscopy, and skin biopsy to distinguish LMM from benign lesions and confirm the presence of melanoma.
• Surgical removal (excision or Mohs surgery) is the most effective treatment, while non-surgical options like radiation therapy or topical treatments may be considered for patients unable to undergo surgery.
• Regular dermatological follow-ups and self-skin checks are essential to monitor for recurrence and detect new melanomas early.
• Sun protection strategies—including daily sunscreen use, protective clothing, and avoiding tanning beds—are crucial in preventing LMM and reducing overall melanoma risk.
• Advancements in artificial intelligence, immunotherapy, and targeted therapy are improving melanoma detection and treatment, offering new hope for better long-term outcomes.

LMM is highly treatable when caught early, making routine skin checks and sun protection the best defenses against this form of melanoma.